BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32859812)

  • 1. ISNO Position Statement on Treatment Guidance in Neuro-oncology During Pandemics.
    Gupta T; Singh VP; Balasubramian A; Menon H; Kurkure PA; Kumar S; Jalali R
    Neurol India; 2020; 68(4):769-773. PubMed ID: 32859812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
    Weinkove R; McQuilten ZK; Adler J; Agar MR; Blyth E; Cheng AC; Conyers R; Haeusler GM; Hardie C; Jackson C; Lane SW; Middlemiss T; Mollee P; Mulligan SP; Ritchie D; Ruka M; Solomon B; Szer J; Thursky KA; Wood EM; Worth LJ; Yong MK; Slavin MA; Teh BW
    Med J Aust; 2020 Jun; 212(10):481-489. PubMed ID: 32401360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.
    Ramakrishna R; Zadeh G; Sheehan JP; Aghi MK
    J Neurooncol; 2020 May; 147(3):525-529. PubMed ID: 32274630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensus.
    Manjandavida FP; Honavar SG; Kim U; Singh U; Menon V; Das S; Kaliki S; Palanivelu MS; Khetan V; Shah PK; Rishi P; Mulay K; Gandhi A; Vadhiraja BM; Reddy VA; Bhat S; Rao V
    Indian J Ophthalmol; 2020 Jul; 68(7):1281-1291. PubMed ID: 32587152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. May we deliver neuro-oncology in difficult times (e.g. COVID-19)?
    Perin A; Servadei F; DiMeco F;
    J Neurooncol; 2020 May; 148(1):203-205. PubMed ID: 32277379
    [No Abstract]   [Full Text] [Related]  

  • 6. How we treat patients with brain tumour during the COVID-19 pandemic.
    Weller M; Preusser M
    ESMO Open; 2020 May; 4(Suppl 2):e000789. PubMed ID: 32409298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.
    Segelov E; Underhill C; Prenen H; Karapetis C; Jackson C; Nott L; Clay T; Pavlakis N; Sabesan S; Heywood E; Steer C; Lethborg C; Gan HK; Yip D; Karanth N; Karikios D; MacIntyre CR
    JCO Oncol Pract; 2020 Aug; 16(8):467-482. PubMed ID: 32401686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
    Mauri D; Kamposioras K; Tolia M; Alongi F; Tzachanis D;
    Lancet Oncol; 2020 Jun; 21(6):759-760. PubMed ID: 32410877
    [No Abstract]   [Full Text] [Related]  

  • 10. Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel.
    Shanthanna H; Strand NH; Provenzano DA; Lobo CA; Eldabe S; Bhatia A; Wegener J; Curtis K; Cohen SP; Narouze S
    Anaesthesia; 2020 Jul; 75(7):935-944. PubMed ID: 32259288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncology care in a lower middle-income country during the COVID-19 pandemic.
    Trehan A; Jain R; Bansal D
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28438. PubMed ID: 32542968
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement.
    Malek M; Hosseinpanah F; Aghaei Meybodi HR; Jahed SA; Hadaegh F; Sharghi S; Esteghamati A; Khamseh ME
    Arch Iran Med; 2020 Aug; 23(8):564-567. PubMed ID: 32894970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.
    Gharzai LA; Resnicow K; An LC; Jagsi R
    JAMA Oncol; 2020 Sep; 6(9):1424-1428. PubMed ID: 32761102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients with cancer in the COVID-19 era: the clinical trial issue.
    Scarcia M; Ludovico GM; Fortunato A; Fiorentino A
    Tumori; 2020 Aug; 106(4):271-272. PubMed ID: 32508257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncology: navigating the COVID-19 Pandemic and Steer the Course].
    Zimmermann S; Dietrich PY; Michielin O; Betticher D; Peters S
    Rev Med Suisse; 2020 Apr; 16(N° 691-2):819-822. PubMed ID: 32348043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism - a consensus report by the emirates oncology task force.
    Al-Shamsi HO; Abu-Gheida I; Rana SK; Nijhawan N; Abdulsamad AS; Alrawi S; Abuhaleeqa M; Almansoori TM; Alkasab T; Aleassa EM; McManus MC
    BMC Cancer; 2020 Jul; 20(1):641. PubMed ID: 32650756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COVID 19 and cancer: What are the consequences of the cancer care reorganization?].
    El Amrani M; Truant S; Turpin A
    Bull Cancer; 2020 May; 107(5):538-540. PubMed ID: 32359766
    [No Abstract]   [Full Text] [Related]  

  • 19. Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.
    Viale G; Licata L; Sica L; Zambelli S; Zucchinelli P; Rognone A; Aldrighetti D; Di Micco R; Zuber V; Pasetti M; Di Muzio N; Rodighiero M; Panizza P; Sassi I; Petrella G; Cascinu S; Gentilini OD; Bianchini G
    Oncologist; 2020 Jul; 25(7):e1013-e1020. PubMed ID: 32412693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [French Society for Surgical Oncology (SFCO) guidelines for the management of surgical oncology in the pandemic context of COVID 19].
    Classe JM; Dolivet G; Evrard S; Ferron G; Lécuru F; Leufflen L; Rivoire M; Sgarbura O
    Bull Cancer; 2020 May; 107(5):524-527. PubMed ID: 32307107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.